Table 4 Most frequently identified carbapenemase-encoding alleles and the corresponding reported geographic regions of the world and countries for persons who were recently hospitalized abroad, January 2017–June 2019a, the Netherlands
Carbapenemase-encoding allele (WGS) | Number of persons being hospitalized abroad for > 24 h during the previous two monthsb (n) | Geographic region(s) most frequently reported (n) | Most prevalent countries (n) |
|---|---|---|---|
blaOXA-48 | 84 | Northern Africa (35) | Morocco (29) |
Western Asia (30) | Turkey (29) | ||
Southern Europe (6) | Egypt (4) | ||
Spain (4) | |||
blaNDM-1 | 37 | Southern Europe (9) | Greece (5) |
South-eastern Asia (6) | Turkey (4) | ||
Northern Africa (5) | India (3) | ||
Western Asia (5) | Thailand (3) | ||
South Asia (5) | |||
blaNDM-5 | 29 | Southern Asia (12) | India (10) |
Northern Africa (10) | Egypt (7) | ||
Morocco (3) | |||
blaOXA-181 | 22 | South Asia (11) | India (7) |
South-eastern Asia (4) | Turkey (4) | ||
Western Asia (4) | Thailand (3) | ||
blaKPC-2 | 15 | Southern Europe (8) | Greece (6) |
Western Asia (4) | Turkey (3) | ||
blaOXA-244 | 13 | Western Asia (6) | Turkey (6) |
Northern Africa (4) | Egypt (3) | ||
blaKPC-3 | 12 | Southern Europe (11) | Italy (8) |
Portugal (3) | |||
blaVIM-1 | 11 | Southern Europe (9) | Spain (5) |